Decreased Expression of 14-3-3σ in Neuroendocrine Tumors Is Independent of Origin and Malignant Potential

Oncogene - United Kingdom
doi 10.1038/sj.onc.1206014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Methylation of 14‑3‑3σ Gene and Prognostic Significance of 14‑3‑3σ Expression in Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2017English

A Structural Basis for 14-3-3σ Functional Specificity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2014English

14-3-3ϵ and 14-3-3σ Inhibit Toll-Like Receptor (TLR)-mediated Proinflammatory Cytokine Induction

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

The Origin of Neuroendocrine Tumors and the Neural Crest Saga

Modern Pathology
Forensic MedicinePathology
2011English

Outcomes After Surgery for Malignant Pancreatic Neuroendocrine Tumors

Kurdistan Journal of Applied Research
2019English

Outcomes After Surgery for Malignant Pancreatic Neuroendocrine Tumors

Kurdistan Journal of Applied Research
2019English

Expression of Transcription Factors in MEN1-associated Pancreatic Neuroendocrine Tumors

Endocrinology, Diabetes and Metabolism Case Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

PAX2 Expression in Low Malignant Potential Ovarian Tumors and Low-Grade Ovarian Serous Carcinomas

Modern Pathology
Forensic MedicinePathology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy